[This corrects the article DOI: 10.7150/thno.34020.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797671 | PMC |
| http://dx.doi.org/10.7150/thno.56734 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
Clin Epigenetics
December 2024
The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Corrigendum to "Asiaticoside-nitric oxide promoting diabetic wound healing through the miRNA-21-5p/TGF-β1/SMAD7/TIMP3 signaling pathway" [J. Ethnopharmacol. 319 (2024) 117266].
J Ethnopharmacol
January 2025
College of Pharmacy, Zunyi Medical University, Zunyi, 563006, China; Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi, 563006, China; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, QLD, 4072, Australia. Electronic address:
Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP.
Cancer Gene Ther
November 2023
Department of Laboratory Medicine, The University of Texas MD Anderson Cancer, Houston, TX, USA.
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Clin Epigenetics
July 2022
The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!